ASUS LU800 Handheld Ultrasound Device Secures US FDA 510(k) Approval
ASUS Enters the US Medical Device Market with FDA Clearance for LU800 Handheld Ultrasound
TAIPEI, Taiwan — January 12, 2026 — ASUS has reached a major milestone in its healthcare journey. The company announced that its Handheld Ultrasound LU800 has received 510(k) clearance from the US Food and Drug Administration (FDA), marking ASUS’s first Class II medical device approval in the United States.
This approval represents ASUS’s official entry into the US medical device market and highlights its growing focus on intelligent, technology-driven healthcare solutions.
What FDA 510(k) Clearance Means
FDA 510(k) clearance is a globally recognized regulatory standard that confirms a medical device is safe, effective, and substantially equivalent to existing approved devices. For ASUS, this clearance validates the LU800’s performance, quality, and compliance with strict FDA regulatory and quality management requirements—credentials trusted by hospitals and healthcare providers worldwide.
Designed for Point-of-Care Ultrasound (POCUS)
The ASUS Handheld Ultrasound LU800 is a lightweight, wireless ultrasound system designed specifically for point-of-care use. Its compact form factor allows it to be used across diverse clinical settings, including emergency rooms, ambulances, outpatient facilities, and even remote or rural clinics.
Despite its small size, the LU800 packs powerful capabilities:
- 128-channel beamformer
- Five advanced imaging modes
- Full DICOM support for medical imaging workflows
These features enable high-quality imaging and fast measurements, helping clinicians make quicker and more accurate diagnostic decisions.
A First in the Handheld Ultrasound Space
One of the LU800’s standout innovations is its cross-platform compatibility. It is the world’s first handheld ultrasound device to support Android, iOS, Chrome OS, and Windows, transforming it from a single-purpose device into a future-ready diagnostic platform that integrates seamlessly with existing clinical systems.
ASUS on the Future of Smart Healthcare
Commenting on the achievement, ASUS COO and Senior Vice President Joe Hsieh emphasized that the FDA clearance represents more than regulatory success.
According to Hsieh, the LU800 reflects ASUS’s long-term commitment to smart healthcare research and development. By combining AI algorithms, wireless communication, medical imaging expertise, and system integration, ASUS aims to deliver real-time, high-quality imaging tools that are easy to deploy and practical for everyday clinical use.
ASUS is also actively developing AI-guided ultrasound scanning applications that provide real-time guidance during scans. These tools are designed to reduce the learning curve for ultrasound operation, allowing non-specialist users to capture clinically relevant images more effectively—ultimately improving accessibility and patient care.
Accelerating Global Expansion
With FDA clearance secured, ASUS plans to accelerate the global rollout of its handheld ultrasound solutions. The company is targeting regions with rising demand for smart and remote healthcare, including Southeast Asia and South America, with the goal of expanding access to advanced medical imaging technologies worldwide.
About The Author
